These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6958312)

  • 1. Long-term survival in myelomatosis. A report to the MRC working party on leukaemia in adults.
    Buckman R; Cuzick J; Galton DA
    Br J Haematol; 1982 Dec; 52(4):589-99. PubMed ID: 6958312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic features in the third MRC myelomatosis trial. Medical Research Council's Working Party on Leukaemia in Adults.
    Br J Cancer; 1980 Dec; 42(6):831-40. PubMed ID: 7459218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report on the second myelomatosis trial after five years of follow-up. Medical Research Council's Working Party on Leukaemia in Adults.
    Br J Cancer; 1980 Dec; 42(6):813-22. PubMed ID: 7006663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report on the first myelomatosis trial. I. Analysis of presenting features of prognostic importance.
    Br J Haematol; 1973 Jan; 24(1):123-39. PubMed ID: 4805842
    [No Abstract]   [Full Text] [Related]  

  • 5. Monitoring myelomatosis.
    Hobbs JR
    Arch Intern Med; 1975 Jan; 135(1):125-30. PubMed ID: 1111461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of myelomatosis--M.R.C. trial.
    Galton DA
    Br Med J; 1971 May; 2(5757):323-4. PubMed ID: 4930211
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment comparisons in the third MRC myelomatosis trial. Medical Research Council's Working Party on Leukaemia in Adults.
    Br J Cancer; 1980 Dec; 42(6):823-30. PubMed ID: 7006664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults.
    Cuzick J; Erskine S; Edelman D; Galton DA
    Br J Cancer; 1987 May; 55(5):523-9. PubMed ID: 3300761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelomatosis: comparison of melphalan and cyclophosphamide therapy.
    Br Med J; 1971 Mar; 1(5750):640-1. PubMed ID: 4926948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical classes of myelomatosis. Including data from a therapeutic trial conducted by a Medical Research Council working party.
    Hobbs JR
    Br J Haematol; 1969 Jun; 16(6):599-606. PubMed ID: 4184690
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis. The Medical Research Council Working Party for Leukaemia in Adults.
    MacLennan IC; Chapman C; Dunn J; Kelly K
    Lancet; 1992 Jan; 339(8787):200-5. PubMed ID: 1346171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma--development of alternative malignancy following successful chemotherapy.
    Holt JM; Robb-Smith AH; Callender ST; Spriggs AI
    Br J Haematol; 1972 May; 22(5):633. PubMed ID: 4503794
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of early paraprotein response to vincristine-doxorubicin-dexamethasone chemotherapy may help guide therapy in multiple myeloma.
    Ross DM; To LB; Horvath N
    Intern Med J; 2004; 34(9-10):576-8. PubMed ID: 15482273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis and management of renal failure in fourth MRC myelomatosis trial. MRC working party on leukaemia in adults.
    Br Med J (Clin Res Ed); 1984 May; 288(6428):1411-6. PubMed ID: 6326927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of myelomatosis on treatment with prednisone and cytostatics.
    Hansen OP; Jessen B; Videbaek A
    Scand J Haematol; 1973; 10(4):282-90. PubMed ID: 4764610
    [No Abstract]   [Full Text] [Related]  

  • 16. A progress report on the Medical Research Council's therapeutic trial in myelomatosis.
    Galton DA; Peto R
    Br J Haematol; 1968 Sep; 15(3):319-20. PubMed ID: 5696221
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prognosis in myelomatosis treated with prednisone and cytostatics].
    Hansen OP; Jessen B; Videbaek A
    Ugeskr Laeger; 1973 Jun; 135(23):1169-73. PubMed ID: 4757116
    [No Abstract]   [Full Text] [Related]  

  • 18. Objective evaluation of the role of vincristine in induction and maintenance therapy for myelomatosis. Medical Research Council Working Party on Leukaemia in Adults.
    MacLennan IC; Cusick J
    Br J Cancer; 1985 Aug; 52(2):153-8. PubMed ID: 3896288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hemodialysis in myelomatosis.
    Leech SH; Polesky HF; Shapiro FL
    Ann Intern Med; 1972 Aug; 77(2):239-42. PubMed ID: 4641657
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multiple myeloma and terminal acute myeloid leukaemia (author's transl)].
    Labedzki L; Fuchs HJ; Grips KH
    Dtsch Med Wochenschr; 1976 Jan; 101(4):108-11. PubMed ID: 812690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.